Navigation Links
PAGE in Medical Technology

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

... and low bone mass in our nation. 2002; page 18 (3) National Osteoporosis Foundation. ... and low bone mass in our nation. 2002; page 18 (4) National Osteoporosis Foundation ... , accessed, 3/27/2009: page #4, Paragraph 4 (6) Burge R, et al, ...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... Registration Trial Number: NCT00125918. page 3. (2)Galie, N., et al. "Tadalafil therapy for ... Registration Trial Number: NCT00125918. page 6. (3)Galie, N., et al. "Tadalafil therapy for ... Registration Trial Number: NCT00125918. page 6. (4)Galie, N., et al. "Tadalafil therapy for ...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... October 2008, were presented: Abstract book page 27: Prophylactic Therapy Considerations in ... Abstract book page 46: Subcutaneous Infusion of Cinryze in Pigs ... HAE patients. Abstract book page 47: The Effect of Cinryze on Key Pathways in HAE ...

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture

... by clicking the "For Investors" tab on the home page of the Company's web site at http://www . ... electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of the Company's home page on the Internet at http://www.auxilium.com ...

Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)

... (the "SEC") and may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of the Company's home page on the Internet at http://www.auxilium.com under the heading "Investor ...

Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)

... from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate website at http://www.trubion.com/ . Trubion undertakes no duty to update any forward-looking statement to conform ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... (international), conference ID# 97738057. To access the live audio webcast of the conference call, please log on to the investor relations page of the company's website at www.intermune.com . The company recommends logging on to the site 15 minutes prior to the start of the presentation ...

Type 2 Diabetes: An Epidemic Among America's Youth

... prediabetes, type 1 and type 2 diabetes, diabetes complications, and tips on how diabetes patients can best prepare for disaster. A short, one page bio and high resolution photo of Francine R. Kaufman, MD, is available by clicking here . About AACE AACE is a professional medical ...

Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update

... by telephone, please dial 877-741-4240 from the U.S. or 719-325-4751 for international callers. The Webcast can be accessed on the "Events" page of the "News & Events" section of the Company's Web site at http://www.poniard.com . A replay of the Webcast will be available on the ...

Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting

... from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com . Trubion undertakes no duty to update any forward-looking statement to conform ...

New Aspirin Recommendation Can Help Prevent Heart Attacks & Strokes, Says Partnership for Prevention

... for clinicians." More information about Partnership for Prevention's initiative can be found at www.prevent.org/content/view/227/205 . The page includes a podcast with Dr. Nieca Goldberg discussing the new aspirin recommendation. Dr. Goldberg is a member of Partnership's Task Force on ...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

... by telephone, please dial 877-719-9791 from the U.S. or 719-325-4811 for international callers. The Web cast can be accessed on the "Events" page of the "News & Events" section of the Company's Web site at http://www.poniard.com . A replay of the Web cast will be available on the Company's ...

Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)

... Time (ET)/2:00 p.m. Pacific Time (PT). A live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com . To access the conference call by telephone, please follow ...

Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile

... of CDI are estimated to be around $4.4bn per year.(3) Additional information is available at the UK Health Protection Agency C. difficile information page (4) and at http://www.sanofipasteur.com/cdiff About sanofi-aventis Sanofi-aventis, a leading global pharmaceutical company, ...

MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series

... DSC127 was licensed from the University of Southern California in Q4 of 2007. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com . Contact: Derma Sciences, Inc. Edward J. Quilty Chairman and CEO ...

Savient Provides Update on Pegloticase BLA

... and answer period will follow the Company's prepared remarks. Both the live and archived web cast can be accessed from the Investor Relations page of Savient's website at http://www.savient.com . A digital recording of the web cast will be available within two hours following the ...

Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis

... through its partnership with the American Thoracic Society (ATS). Complete details on CPF activities, including research, are available on our web page at: http://www.coalitionforpf.org/cpf_accomplishments.php . "While this study does not represent a cure, it IS a historic first step in ...

InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3

... conference ID# 84164912. To access the live webcast of the conference call, with accompanying slides, please log on to the investor relations page of the company's website at http://www.intermune.com . The company recommends logging on to the site 15 minutes prior to the start of the ...

GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.

... and then returns them to GeneThera's lab for testing and reporting of the results. The results will be available to customers via a secured web page on GeneThera's website. Everything is included in the price from GeneThera. Pricing is expected to be between $25 and $32 per test, and results are ...

Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinson's Disease Research

... descriptions follow. Full details are available at http://www.michaeljfox.org/research.cfm . The Foundation has redesigned its Funding Opportunities page to enhance ease of use and provide researchers with a better understanding of how various programs fit into the larger context of the MJFF ...

Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference

... ANA773 in hepatitis C and ANA773 in cancer. The presentation will be simultaneously webcast and can be accessed on the Investor Relations page of the Company's website at http://www.anadyspharma.com . Listeners are encouraged to visit the website approximately five minutes prior to the ...

APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism

... relaxed while en route. The APTA "In Flight Fitness Guide," featuring a selection of recommended exercises, can be found on APTA's Consumer Web page at http://www.apta.org/consumer . "Simple exercise can help prevent other typical symptoms experienced by people who fly, including leg cramping, ...

Derma Sciences' MEDIHONEY(TM) Proven to Speed Healing in Stalled Leg Ulcers

... a Phase II study, with anticipated initial patient enrollment to begin in Q3 of 2008. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com . Contact: Derma Sciences, Inc. Allen & Caron Inc Edward J. Quilty ...

CDC Misses Target With Flawed MMR/Autism Study

... age and sex matched controls? 2. In the current CDC study, only a small subgroup of children was the correct phenotype to study. From page 7, "Only 5 of 25 subjects (20%) had received MMR before the onset of GI complaints and had also had onset of GI episodes before the onset of AUT ....

Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event

... will be webcast live today beginning at 1pm Eastern Time/5pm GMT/6pm British Summer time. The webcast can be accessed through the Investors page on deCODE's website, http://www.decode.com, and those interested in listening should log on a few minutes in advance in order to download any ...

DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin

... the results of this study in detail at the company's annual R&D event to be webcast live today beginning at 1pm Eastern Time through the investor's page of the company's website, http://www.decode.com . "These findings underscore the potential of DG041 as a next-generation oral anti-platelet: a ...

TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate

... cord trauma, stroke and multiple sclerosis. Webinar Information Participants can access the Webinar by clicking on the link located on the home page of TorreyPines Therapeutics' Web site at http://www.torreypinestherapeutics.com . Individuals interested in asking questions should also participate ...

Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration

... from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com . Trubion undertakes no duty to update any forward-looking statement to conform ...

Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers

... a Phase II study, with anticipated initial patient enrollment to begin in Q3 of 2008. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com . About the Journal of Wound Care (JWC) JWC is the definitive wound-care journal and the leading ...

Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting

... from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com . Trubion undertakes no duty to update any forward-looking statement to conform ...

Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine

... statements and other relevant documents filed with the SEC by Iomai free of charge (when they are available) by going to Iomai's Investor Relations page on its corporate website at http://www.iomai.com . Iomai and its directors, executive officers and other members of management may be deemed to be ...

Trubion Announces Presentation of Positive TRU-016 Data at ASCO

... from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com . Trubion undertakes no duty to update any forward-looking statement to conform the ...

Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO

... additional data on XL147, a PI3K inhibitor, and XL281, an inhibitor of RAF. The event will be webcast and may be accessed in the Event Calendar page under Investors at http://www.exelixis.com . An archived replay of this webcast will be available until 9:00 p.m. PT/12:00 a.m. ET on July 2, 2008. ...

Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO

... additional data on XL147, a PI3K inhibitor, and XL281, an inhibitor of RAF. The event will be webcast and may be accessed in the Event Calendar page under Investors at http://www.exelixis.com . An archived replay of this webcast will be available until 9:00 p.m. PT/12:00 a.m. ET on July 2, 2008. ...

Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System

... fusion. The company also currently has 75 TOPS(TM) patients enrolled under single and multi-level protocols in Brazil, Belgium, Turkey, and Israel. page 2 of 2 Impliant is applying cutting-edge materials and crossbar biomechanical techniques to develop a new class of spine arthroplasty devices that ...

Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis

... or +1-719-325-4854 for international callers. In addition, the live conference call is being webcast and can be accessed on the "News & Events" page of the Company's website at http://www.ardeabio.com . A replay will also be available on Ardea's website for 14 days and by telephone through May ...

InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA

... ID# 48122233. To access a live audio webcast of the conference call, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com . The company recommends logging on to the site 15 minutes prior to the start of ...

Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures

... was recently the focus of a large scale randomized controlled trial on leg ulcers. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com . Contact: Derma Sciences Inc Allen & Caron Inc Edward J. Quilty ...

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation

... of the proxy statement and other relevant documents filed with the SEC by Iomai (when they are available) by going to Iomai's Investor Relations page on its corporate website at http://www.iomai.com . Iomai and its directors, executive officers and other members of management may be deemed to be ...

Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis

... from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com . Trubion undertakes no duty to update any forward-looking statement to conform the ...
Other Contents
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst ... time half of the world,s population will have a ... Europe . Asia ... the market accounting for more than 60% of all ... Acuity,s report  -- "The Global National eID ...
(Date:10/18/2014)... patients with undiagnosed, suspected genetic conditions, a certain type ... molecular diagnostic yield than traditional molecular diagnostic methods, according ... study is being released to coincide with the American ... which sequences the protein­coding region of the genome (the ... a cell or organism), has been rapidly applied in ...
(Date:10/16/2014)... the human body. Battles are won, lost or ... this stalemate—known as tumor dormancy—can last up to ... that is poorly understood. , A new ... Torquato, a Professor of Chemistry at Princeton University, ... and the switch to a malignant state. Published ...
Breaking Biology News(10 mins):Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Modeling tumor dormancy 2
(Date:10/22/2014)... Although there are only 24 hours in a day, ... have trouble finding time within their busy schedules for exercise and ... of time to get in shape. Here are five ways you ... , Change Up Your Commute , Consider riding a bike ... exercise into your daily routine. If you must use your car ...
(Date:10/22/2014)... 2014 Akeso Biomedical, Inc. , ... treatment of bacterial infections, microbial biofilms, and chronic wounds, ... board of directors. , Dr. Sinskey ... The Massachusetts Institute of Technology, or MIT. He has ... Dr. Sinskey also holds positions as Co-Director of the ...
(Date:10/22/2014)... Two sisters in high school have developed ways to ... Krishen use electronic stethoscopes, which electronically amplify body sounds, ... or heartbeats. Ilina, a senior at Port Huron ... way to detect early lung damage in people exposed ... recorded one breath cycle each from 16 smokers, 25 ...
(Date:10/22/2014)... -- Measures taken by Firestone officials at the company,s ... limited the spread of the disease there and could ... Rubber Co. provides health services to about 80,000 employees, ... communities. Between Aug. 1 and Sept. 23, there ... 80,000 people. That incidence rate of 0.09 percent was ...
(Date:10/20/2014)... Texas (PRWEB) October 20, 2014 The ... the must-have source of thousands of facts, figures and ... countries and 68 medical sector forecast categories the ... with global, regional and national views on the worldwide ... outlook. , The report gives you data for 2010-2019, ...
Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4
Other TagsOther Tags